May 08, 2025

FDA Warns Physicians of Tianeptine Dangers

The FDA warns physicians about unapproved tianeptine products that are linked to severe adverse events, including dependence, toxicity, and death.

Conexiant

May 08, 2025

Mindfulness Therapy May Reduce Opioid Craving Signals

Mindfulness training helped normalize brain responses to positive emotion in people with opioid use disorder, reducing their craving and improving emotional regulation.

Conexiant

May 08, 2025

Early Menopause Linked to Long-Term Cognitive Decline, Study

A large UK-based cohort study found that early menopause—before age 40—is associated with both higher depressive symptoms and worse cognitive function over time.

Conexiant

May 08, 2025

Diet Patterns Affect Menarche Timing

New research reveals healthier diets delay menarche while inflammatory diets accelerate it, potentially impacting long-term health outcomes in women regardless of BMI.

Conexiant

May 08, 2025

Doctors Gas Up Vulvovaginal Patients: Study

New research reveals over 50% of patients with vulvovaginal disorders considered abandoning care due to dismissive clinician behaviors, with many reporting their symptoms were disbelieved or trivialized.

Conexiant

May 07, 2025

FDA Approves Low-Dose Chlorthalidone Tablet

The FDA has approved HemiClor, a 12.5-mg chlorthalidone tablet, providing patients with a low-dose option.

Conexiant

May 06, 2025

FDA Approves TAVR Platform for Asymptomatic AS

The FDA has approved the SAPIEN 3 TAVR platform for patients with asymptomatic severe aortic stenosis based on data from the EARLY TAVR trial.

Conexiant

May 06, 2025

New SCIA Flap Option Shows Safe Results

A new breast reconstruction technique using the superficial branch of the SCIA flap showed safe outcomes in 4 women, offering an alternative to DIEP flaps with less abdominal trauma.

Conexiant

May 05, 2025

Missed Screenings? Anal Cancer Surge in Women

Rates rising 4.3% in white women over 65, outpacing increases in other demographics.

Conexiant